Assessment of Gray Matter Microstructure and Synaptic Density in Alzheimer's Disease: A Multimodal Imaging Study With DTI and SV2A PET

被引:9
|
作者
Silva-Rudberg, Jason A. [1 ,2 ]
Salardini, Elaheh [1 ,2 ]
O'Dell, Ryan S.
Chen, Ming-Kai [3 ]
Ra, Jocelyn [1 ,2 ]
Georgelos, Jamie K. [1 ,2 ]
Morehouse, Mackenzie R. [1 ,2 ]
Melino, Kaitlyn P. [1 ,2 ]
Parma, Pradeep [3 ]
Toyonaga, Takuya [3 ]
Nabulsi, Nabeel B. [3 ]
Huang, Yiyun [3 ]
Carson, Richard E. [3 ]
van Dyck, Christopher H. [2 ,3 ]
Mecca, Adam P. [1 ,2 ,4 ]
机构
[1] Yale Univ, Alzheimers Dis Res Unit, Sch Med, New Haven, CT USA
[2] Yale Univ, Dept Psychiat, Sch Med, New Haven, CT USA
[3] Yale Univ, Dept Radiol & Biomed Imaging, Sch Med, New Haven, CT USA
[4] Yale Univ, Alzheimers Dis Res Unit, Sch Med, One Church St,8th Floor, New Haven, CT 06510 USA
来源
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; diffusion tensor imaging; synaptic density; gray matter microstructure SV2A; positron emission tomography; VOLUME; DIFFUSIVITY; PROGRESSION; BURDEN; RISK; TAU; MCI;
D O I
10.1016/j.jagp.2023.08.002
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: Multimodal imaging techniques have furthered our understanding of how different aspects of Alzheimer's disease (AD) pathology relate to one another. Diffusion tensor imaging (DTI) measures such as mean diffusivity (MD) may be a surrogate measure of the changes in gray matter structure associated with AD. Positron emission tomography (PET) imaging of synaptic vesicle glycoprotein 2A (SV2A) has been used to quantify synaptic loss, which is the major pathological correlate of cognitive impairment in AD. In this study, we investigated the relationship between gray matter microstructure and syn-aptic density. Methods: DTI was used to measure MD and [11C]UCB-J PET to measure synaptic density in 33 amyloid-positive participants with AD and 17 amyloid-negative cognitively normal (CN) participants aged 50-83. Univari-ate regression analyses were used to assess the association between synaptic density and MD in both the AD and CN groups. Results: Hippocampal MD was inversely associated with hippocampal synaptic density in participants with AD (r = -0.55, p <0.001, df = 31) but not CN (r = 0.13, p = 0.62, df = 15). Explor-atory analyses across other regions known to be affected in AD suggested wide-spread inverse associations between synaptic density and MD in the AD group. Conclusion: In the setting of AD, an increase in gray matter MD is inversely asso-ciated with synaptic density. These co-occurring changes may suggest a link between synaptic loss and gray matter microstructural changes in AD. Imaging studies of gray matter microstructure and synaptic density may allow important insights into AD-related neuropathology. (Am J Geriatr Psychiatry 2024; 32:17-28)
引用
收藏
页码:17 / 28
页数:12
相关论文
共 50 条
  • [1] Assessment of Gray Matter Microstructure and Synaptic Density in Alzheimer's Disease: A Multimodal Imaging Study With DTI and SV2A PET: A Commentary on Silva-Rudberg et al.
    Fu, Jessie Fanglu
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2024, 32 (01): : 29 - 31
  • [2] Measuring Synaptic Density in Parkinson's Disease With SV2A PET imaging
    Matuskey, David
    Dias, Mark
    Naganawa, Mika
    Toyonaga, Takuya
    Henry, Shannan
    Ropchan, Jim
    Nabulsi, Nabeel
    Huang, Yiyun
    Suridjan, Ivonne
    Comley, Robert
    Finnema, Sjoerd J.
    Tinaz, Sule
    Carson, Richard E.
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2019, 31 (03) : E19 - E19
  • [3] IMAGING SYNAPTIC DENSITY WITH PET RADIOTRACERS FOR SV2A, A NEW BIOMARKER FOR ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS
    Huang, H.
    Li, S.
    Cai, Z.
    Nabulsi, N.
    Holden, D.
    Ropchan, J.
    Carson, R.
    INTERNAL MEDICINE JOURNAL, 2018, 48 : 11 - 11
  • [4] Initial Experience with PET Imaging of Synaptic Density (SV2A) in Alzheimer's Disease: A New Biomarker for Clinical Trials?
    Mecca, Adam P.
    Chen, Ming-Kai
    Naganawa, Mika
    Finnema, Sjoerd J.
    Toyonaga, Takuya
    Lin, Shu-fei
    McDonald, Julia W.
    Michalak, Hannah R.
    Nahulsi, Naheel B.
    Huang, Yiyun
    Arnsten, Amy F.
    Carson, Richard E.
    van Dyck, Christopher H.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 26 (03): : S145 - S146
  • [5] In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET
    Mecca, Adam P.
    Chen, Ming-Kai
    O'Dell, Ryan S.
    Naganawa, Mika
    Toyonaga, Takuya
    Godek, Tyler A.
    Harris, Joanna E.
    Bartlett, Hugh H.
    Zhao, Wenzhen
    Nabulsi, Nabeel B.
    Vander Wyk, Brent C.
    Varma, Pradeep
    Arnsten, Amy F. T.
    Huang, Yiyun
    Carson, Richard E.
    van Dyck, Christopher H.
    ALZHEIMERS & DEMENTIA, 2020, 16 (07) : 974 - 982
  • [6] Imaging the Effect of Ketamine on Synaptic (SV2A) Density
    Holmes, Sophie
    Finnema, Sjoerd
    Naganawa, Mika
    DellaGioia, Nicole
    Holden, Daniel
    Fowles, Krista
    Ropchan, Jim
    Emory, Paul
    Ye, Yunpeng
    Nabulsi, Nabeel
    Matuskey, David
    Angarita, Gustavo
    Duman, Ronald
    Sanacora, Gerard
    Krystal, John
    Carson, Richard
    Esterlis, Irina
    BIOLOGICAL PSYCHIATRY, 2021, 89 (09) : S35 - S35
  • [7] SV2A synaptic density PET may be affected by neuronal activity
    Toyonaga, T.
    Cai, Z.
    Holden, D.
    Fowles, K.
    Finnema, S. J.
    Huang, Y.
    Carson, R. E.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 : 165 - 165
  • [8] The relationship between cortical synaptic terminal density marker SV2A and glutamate early in the course of schizophrenia: a multimodal PET and MRS imaging study
    Onwordi, Ellis Chika
    Whitehurst, Thomas
    Shatalina, Ekaterina
    Carr, Richard
    Mansur, Ayla
    Arumuham, Atheeshaan
    Osugo, Martin
    Marques, Tiago Reis
    Jauhar, Sameer
    Gupta, Susham
    Pappa, Sofia
    Mehrotra, Ravi
    Ranger, Maja
    Rahaman, Nikola
    Rabiner, Eugenii A.
    Gunn, Roger N.
    Natesan, Sridhar
    Howes, Oliver D.
    TRANSLATIONAL PSYCHIATRY, 2025, 15 (01):
  • [9] Diffusion Imaging of Gray Matter Microstructure in Alzheimer's Disease
    Silva-Rudberg, Jason A.
    Mecca, Adam P.
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 101 (02) : 437 - 439
  • [10] Imaging the effect of ketamine on synaptic density (SV2A) in the living brain
    Sophie E. Holmes
    Sjoerd J. Finnema
    Mika Naganawa
    Nicole DellaGioia
    Daniel Holden
    Krista Fowles
    Margaret Davis
    Jim Ropchan
    Paul Emory
    Yunpeng Ye
    Nabeel Nabulsi
    David Matuskey
    Gustavo A. Angarita
    Robert H. Pietrzak
    Ronald S. Duman
    Gerard Sanacora
    John H. Krystal
    Richard E. Carson
    Irina Esterlis
    Molecular Psychiatry, 2022, 27 : 2273 - 2281